Workflow
LYBALBI
icon
Search documents
Alkermes(ALKS) - 2025 Q2 - Earnings Call Transcript
2025-07-29 13:02
Alkermes (ALKS) Q2 2025 Earnings Call July 29, 2025 08:00 AM ET Company ParticipantsSandy Coombs - SVP - Corporate Affairs & IRRichard Pops - Chairman & CEOBlair Jackson - Executive VP & COOTodd Nichols - SVP & Chief Commercial OfficerCraig Hopkinson - EVP, R&D and Chief Medical OfficerMarcus Yountz - VP - Clinical DevelopmentPaul Matteis - Managing Director, Head of Therapeutics ResearchAnastasia Parafestas - Equity Research AssociateAndrea Newkirk - Biotechnolgy Equity ResearchUmer Raffat - Senior Managin ...